AVR vs ENOV: stock comparison and AI forecast
Anteris Technologies Global Corp. (AVR) and Enovis Corp (ENOV) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AVR Anteris Technologies Global Corp.
- Price
- $5.58 -14.3% · 6M
- Market Cap
- $544M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
ENOV Enovis Corp
- Market Cap
- $1.65B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ENOV is 3.0 times larger than AVR by market capitalization ($1.65B against $544M).
- ENOV carries 1.50 times debt per unit of equity, against 0.08 times for AVR.
- Both companies share the SEC industry classification Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AVR | ENOV |
|---|---|---|
| Market Cap | $544M | $1.65B |
| P/B Ratio | 2.16x | 1.11x |
| EPS | $-2.27 | $-10.06 |
| Book Value/Share | $2.58 | $25.89 |
| Revenue/Share | $0.02 | $39.99 |
| FCF/Share | $-0.91 | $1.21 |
Profitability & Margins
| Metric | AVR | ENOV |
|---|---|---|
| ROE | – | -35.3% |
| ROA | – | -14.1% |
| ROIC | -41.8% | -15.1% |
| Gross Margin | – | 61.3% |
| Operating Margin | -6077.5% | -20.6% |
| Net Margin | – | -22.9% |
| EBT Margin | -5859.0% | -21.8% |
| Tax Rate | -0.5% | -5.0% |
Financial Health
| Metric | AVR | ENOV |
|---|---|---|
| Current Ratio | 14.20x | 2.15x |
| Quick Ratio | 14.20x | 1.08x |
| D/E Ratio | 0.08x | 1.50x |
| Financial Leverage | 1.08x | 2.50x |
| Interest Coverage | -298.1x | 0.4x |
| Working Capital | $242M | $668M |
Cash Flow
| Metric | AVR | ENOV |
|---|---|---|
| Operating Cash Flow | -$86M | $259M |
| Free Cash Flow | -$88M | $70M |
| Capital Spending | -$2M | -$189M |
| OCF Growth YoY | – | 19.3% |
| FCF Growth YoY | – | 205.6% |
| FCF/Sales | -5046.3% | 3.0% |
| CapEx/Sales | 111.8% | 8.2% |
Operational Efficiency
| Metric | AVR | ENOV |
|---|---|---|
| Asset Turnover | 0.01x | 0.62x |
| Receivables Turnover | 3.2x | 5.4x |
| Inventory Turnover | 70.1x | 1.4x |
| Fixed Assets Turnover | 0.3x | 4.4x |
| Days Sales Outstanding | 114 days | 68 days |
| Days Inventory | 5 days | 254 days |
| Payables Period | 3318 days | 82 days |
| Cash Conversion Cycle | -3198 days | 239 days |
Income Statement
| Metric | AVR | ENOV |
|---|---|---|
| Total Revenue | $2M | $2.31B |
| Operating Income | -$106M | -$475M |
| Net Income | – | -$527M |
| R&D Expense | $77M | $126M |
| SG&A Expense | $31M | $1.08B |
| Cost of Goods Sold | $560K | $892M |
Dividend & Shareholder Information
| Metric | AVR | ENOV |
|---|---|---|
| Shares Outstanding | 97M | 58M |
AVR vs ENOV: stock comparison and AI forecast
Which is bigger, AVR or ENOV?
ENOV is 3.0 times larger than AVR by market capitalization ($1.65B against $544M).
Which one does Intratio's AI model rank higher, AVR or ENOV?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.